Adapted J6/JFH1-based Hepatitis C virus recombinants with genotype-specific NS4A show similar efficacies against lead protease inhibitors, alpha interferon, and a putative NS4A inhibitor

    Antimicrobial agents and chemotherapy, Volume 57, Issue 12, 2013, Pages 6034-6049.

    Cited by: 9|Bibtex|Views0|Links
    WOS

    Abstract:

    To facilitate studies of hepatitis C virus (HCV) NS4A, we aimed at developing J6/JFH1-based recombinants with genotype 1- to 7-specific NS4A proteins. We developed efficient culture systems expressing NS4A proteins of genotypes (isolates) 1a (H77 and TN), 1b (J4), 2a (J6), 4a (ED43), 5a (SA13), 6a (HK6a), and 7a (QC69), with peak infectiv...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments